Cargando…

Zonisamide in the management of epilepsy in the elderly

Zonisamide (ZNS), a second-generation antiepileptic drug, indicated as add-on treatment of focal epilepsy, has been recently approved as monotherapy for the treatment of partial seizures in adults affected by newly diagnosed epilepsy in Europe. Evidence on the efficacy and tolerability of antiepilep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Romigi, Andrea, Femia, Eti A, Fattore, Cinzia, Vitrani, Giuseppe, Di Gennaro, Giancarlo, Franco, Valentina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467644/ https://www.ncbi.nlm.nih.gov/pubmed/26089654 http://dx.doi.org/10.2147/CIA.S50819

Ejemplares similares

Topiramate-induced periodic limb movement disorder in a patient affected by focal epilepsy
por: Romigi, Andrea, et al.
Publicado: (2014)

Profile of pitolisant in the management of narcolepsy: design, development, and place in therapy
por: Romigi, Andrea, et al.
Publicado: (2018)

Zonisamide Efficacy as Adjunctive Therapy in Children With Refractory Epilepsy
por: KARIMZADEH, Parvaneh, et al.
Publicado: (2013)

Editorial: Epilepsy in older adults: From physiopathology to improvements in diagnosis and management
por: Romigi, Andrea, et al.
Publicado: (2022)

Zonisamide Changes Unilateral Cortical Excitability in Focal Epilepsy Patients
por: Joo, Eun Yeon, et al.
Publicado: (2010)

Long-Term Efficacy and Safety of Zonisamide Monotherapy in Epilepsy Patients
por: Park, Sung-Pa, et al.
Publicado: (2007)

Comparative Efficacy of Zonisamide and Pregabalin as an Adjunctive Therapy in Children with Refractory Epilepsy
por: TAGHDIRI, Mohammad Mahdi, et al.
Publicado: (2015)

Safety and Efficacy of Zonisamide in Patients with Epilepsy: A Post-Marketing Surveillance Study
por: Lee, Hye Jin, et al.
Publicado: (2015)

Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature
por: Zaccara, Gaetano, et al.
Publicado: (2009)

Zonisamide‐responsive myoclonus in SEMA6B‐associated progressive myoclonic epilepsy
por: Herzog, Rebecca, et al.
Publicado: (2021)

Sleep and Epilepsy
por: Romigi, Andrea, et al.
Publicado: (2013)

Epilepsy Care in the Time of COVID-19 Pandemic in Italy: Risk Factors for Seizure Worsening
por: Assenza, Giovanni, et al.
Publicado: (2020)

Update on once-daily zonisamide monotherapy in partial seizures
por: Afra, Pegah, et al.
Publicado: (2014)

Zonisamide Therapy Reduces Metabolic Consequences and Diminishes Nonalcoholic Fatty Liver Disease in Patients with Epilepsy
por: Huang, Chi-Ren, et al.
Publicado: (2021)

Distal renal tubular acidosis and lethargy associated with zonisamide treatment in a dog with idiopathic epilepsy
por: Itoi, Takamasa, et al.
Publicado: (2022)

Evaluation of antiseizure medications including zonisamide in feline idiopathic epilepsy at a referral hospital in Japan
por: Yoshida, Shino, et al.
Publicado: (2023)

Management of epilepsy in the elderly
por: Poza, Juan José
Publicado: (2007)

Zonisamide-induced acute kidney injury
por: Dixit, Deepali, et al.
Publicado: (2015)

Impact of Pregnancy on Zonisamide Pharmacokinetics in Rabbits
por: Matar, Kamal M.
Publicado: (2013)

Repositioning again of zonisamide for nerve regeneration
por: Ohno, Kinji, et al.
Publicado: (2016)

Efficacy of Zonisamide in Migraineurs with Nonresponse to Topiramate
por: Chung, Jin-Young, et al.
Publicado: (2014)

Zonisamide-Induced Hallucinations: An Anticonvulsant’s Psychosis
por: Al Armashi, Abdul Rahman, et al.
Publicado: (2021)

Cognitive Profile of Zonisamide and Valproic Acid in the Treatment of Idiopathic Generalized Epilepsy: A Comparative Observational Study
por: Ramirez-García, Teresa, et al.
Publicado: (2016)

Zonisamide is effective in the preventive therapy of chronic migraine
por: Belvis, R, et al.
Publicado: (2013)

Effect of topiramate and zonisamide on fMRI cognitive networks
por: Wandschneider, Britta, et al.
Publicado: (2017)

Profile of once-daily zonisamide as monotherapy for treatment of partial seizures in adults
por: Mula, Marco
Publicado: (2013)

Bioequivalence of Different Formulations of Zonisamide Oral Suspensions: A Short Review
por: Stević, Ivana, et al.
Publicado: (2023)

Probable drug-induced lupus erythematosus by zonisamide
por: Safadi, Mohannad G., et al.
Publicado: (2021)

Zonisamide – a review of experience and use in partial seizures
por: Wilfong, Angus A, et al.
Publicado: (2006)

Limited efficacy of zonisamide in the treatment of refractory infantile spasms
por: Hussain, Shaun A., et al.
Publicado: (2020)

Silicate Urolithiasis during Long-Term Treatment with Zonisamide
por: Taguchi, Satoru, et al.
Publicado: (2013)

Zonisamide for the Treatment of Parkinson Disease: A Current Update
por: Li, Chengqian, et al.
Publicado: (2020)

Zonisamide Ameliorates Microglial Mitochondriopathy in Parkinson’s Disease Models
por: Tada, Satoshi, et al.
Publicado: (2022)

The Effect of Zonisamide and Ethanol on Various Types of Memory in Rats
por: Pietrzak, Bogusława, et al.
Publicado: (2023)

Zonisamide: A review of the clinical and experimental evidence for its use in Parkinson's disease
por: Grover, Neeta D., et al.
Publicado: (2013)

The Application of Zonisamide to Patients Suffering from Dementia with Lewy Bodies: Emerging Clinical Data
por: Tousi, Babak, et al.
Publicado: (2021)

Therapeutic Salivary Monitoring of Perampanel in Patients with Epilepsy Using a Volumetric Absorptive Microsampling Technique
por: Palmisani, Michela, et al.
Publicado: (2023)

Pharmacokinetics of Single‐Dose Rectal Zonisamide Administration in Normal Dogs
por: Brewer, D.M., et al.
Publicado: (2015)

HPLC Method for Simultaneous Determination of Impurities and Degradation Products in Zonisamide
por: Vijayakumar, E. K. S., et al.
Publicado: (2009)

Nightmare-Enacting Behavior Responding to Zonisamide in Early Parkinson's Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_drqfie9ongjbnhmqa0v7c6fcvs